APC: Psychedelic Facilitated Psychotherapy for Addiction-Slides

Slides

Pdf Summary

The document provides an overview of the Addiction Psychiatry Advanced Psychotherapy Curriculum for 2022, with a focus on psychedelic-assisted psychotherapy for substance use disorders. The author, Dr. Chris Stauffer, discloses his involvement as a paid Supervisor and Trainer of MDMA-assisted psychotherapy. The document includes a disclaimer stating that psilocybin, one of the substances discussed, is currently a Schedule I substance and has no FDA-approved indication for the treatment of substance use disorders.<br /><br />The learning objectives of the curriculum include reviewing the history of psychedelic-assisted psychotherapy, assessing existing literature and ongoing research on the use of psychedelics to treat substance use disorders, and exploring the changing landscape of training and certification for psychedelic-assisted psychotherapy.<br /><br />The document provides information on the different types of psychedelics, such as psilocybin, LSD, and MDMA, and their contexts of use. It also discusses the pharmacokinetics and pharmacodynamics of psilocybin, including its metabolism and receptors it acts on.<br /><br />The document highlights the prevalence of substance use disorders and the potential benefits of psychedelic-assisted psychotherapy in treating alcohol, tobacco, opioid, stimulant, cocaine, and methamphetamine use disorders. It presents findings from studies and ongoing trials that suggest positive outcomes, such as reduced substance use and improved treatment outcomes.<br /><br />The document also touches on topics such as the 12-step model in conjunction with psychedelic-assisted therapy, the debate around the subjective effects of psychedelics, and the potential mechanisms of action for their therapeutic effects.<br /><br />In conclusion, the document provides an overview of the role of psychedelic-assisted psychotherapy in the treatment of substance use disorders, highlighting its potential benefits and ongoing research in the field.

Keywords

Addiction Psychiatry

Psychedelic-assisted psychotherapy

Substance use disorders

Psilocybin

MDMA

Training and certification

Pharmacokinetics

Pharmacodynamics

Positive outcomes

Ongoing research